Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Carcinoma, Anaplastic × sacituzumab govitecan × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Carcinoma, Transitional Cell 3 Urinary Bladder Neoplasms 2 Urothelial Bladder Carcinoma 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Metastatic Urothelial Cancer 1 Lung Neoplasms 1 Localized Muscle Invasive Bladder Urothelial Carcinoma 1 Laryngeal Neoplasms 1 Klatskin Tumor 1 Hypopharyngeal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Small Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

trametinib 2 dabrafenib 2 pembrolizumab 1 Radiotherapy, Intensity-Modulated 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡